Identification of two mutually exclusive groups after long-term monitoring of HIV DNA 2-LTR circle copy number in patients on HAART

AIDS

Volumn 17, Issue 5, 2003, Pages 679-683

  Morlese, John ^a   Teo, Ian A ^a   Choi, Ji Won ^a   Gazzard, Brian ^a   Shaunak, Sunil ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Anti retroviral drugs; HIV DNA; Reservoirs; Surrogate markers

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS DNA; VIRUS RNA;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; MAJOR CLINICAL STUDY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DNA, VIRAL; DRUG MONITORING; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; PROSPECTIVE STUDIES; RNA, VIRAL; VIRUS REPLICATION;

EID: 0037471339     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200303280-00005     Document Type: Article

References (27)

1. Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hammer SM, et al. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA 2000, 283:381-390.
2. Wong JK, Hezareh M, Gunthard HF, Havlir DV, Ignacio CC, Spina CA, et al. Recovery of replication competent HIV despite prolonged suppression of plasma viremia. Science 1997, 278:1291-1295.
3. Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997, 278:1295-1300.
4. Zhang L, Ramratnam B, Tenner-Racz K, He Y, Vesanen M, Lewin S, et al. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N Engl J Med 1999, 340:1605-1613.
5. Pierson T, McArthur J, Siliciano RF. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu Rev Immunol 2000, 18:665-708.
6. Teo I, Veryard C, Barnes H, An SF, Jones M, Lantos PL, et al. Circular forms of unintegrated HIV-1 DNA and high levels of viral protein expression: association with dementia and multi-nucleated giant cells in the brains of patients with AIDS. J Virol 1997, 71:2928-2933.
7. Veazey RS, DeMaria M, Chalifoux LV, Shvetz DE, Pauley DR, Knight HL, et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 1998, 280:427-431.
8. Igarashi T, Brown CR, Endo Y, Buckler-White A, Plishka R, Bischofberger N, et al. Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic SIV/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans. Proc Natl Acad Sci USA 2001, 98:658-663.
9. Eckstein DA, Sherman MP, Penn ML, Chin PS, De Noronha CM, Greene WC, et al. HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells. J Exp Med 2001, 194:1407-1419.
10. Polis MA, Sidorov IA, Yoder C, Jankelevich S, Metcalf J, Mueller BU, et al. Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacy. Lancet 2001, 358:1760-1765.
11. Huang W, De Gruttola V, Fischl M, Hammer S, Richman D, Havlir D, et al. Patterns of plasma HIV-1 RNA response to antiretroviral therapy. J Infect Dis 2001, 183:1455-1465.
12. Barbosa P, Charneau P, Dumey N, Clavel F. Kinetic analysis of HIV-1 early replicative steps in a coculture system. AIDS Res Hum Retroviruses 1994, 10:53-59.
13. Zennou V, Petit C, Guetard D, Nerhbass U, Montagnier L, Charneau P. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 2000, 101:173-185.
14. Panther LA, Coombs RW, Aung SA, dela-Rosa C, Gretch D, Corey L. Unintegrated HIV-1 circular 2-LTR proviral DNA as a marker of recently infected cells: relative effect of recombinant CD4, zidovudine, and saquinavir in vitro. J Med Virol 1999, 58:165-173.
15. Sharkey ME, Teo I, Greenough T, Sharova N, Luzuriaga K, Sullivan JL, et al. Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy. Nature Med 2000, 6:76-81.
16. Teo IA, Choi JW, Morlese J, Taylor G, Shaunak S. LightCycler qPCR optimisation for low copy number target DNA. J Immunol Methods 2002, 270:119-133.
17. Teo IA, Morlese J, Choi JW, Shaunak S. Reliable and reproducible LightCycler qPCR measurement of HIV DNA circles. J Immunol Methods 2002, 270:109-118.
18. Hauber I, Harrer T, Low P, Schmitt M, Schwingel E, Hauber J. Determination of HIV-1 circular DNA as a surrogate marker for residual virus replication in patients with undetectable virus loads. AIDS 2000, 14:2619-2621.
19. Bruggeman LA, Ross MD, Tanji N, Cara A, Dikman S, Gordon RE, et al. Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol 2000, 11:2079-2087.
20. Dornadula G, Zhang H, Shetty S, Pomerantz RJ. HIV-1 virions produced from replicating peripheral blood lymphocytes are more infectious than those from nonproliferating macrophages due to higher levels of intravirion reverse transcripts: implications for pathogenesis and transmission. Virology 1999, 253:10-16.
21. Dornadula G, Nunnari G, Vanella M, Roman J, Babinchak T, DeSimone J, et al. HIV-1 infected persons with residual disease and virus reservoirs on suppressive highly active antiretroviral therapy can be stratified into relevant virologic and immunologic subgroups. J Infect Dis 2001, 183:1682-1687.
22. Shaunak S, Veryard C, Javan C. Severe Pneumocystis carinii pneumonia increases the infectious titre of HIV-1 in blood and can promote the expansion of viral chemokine co-receptor tropism. J Infect 2001, 43:3-6.
23. Pierson TC, Kieffer TL, Ruff CT, Buck C, Gange SJ, Siliciano RF. Intrinsic stability of episomal circles formed during HIV-1 replication. J Virol 2002, 76:4138-4144.
24. Butler SL, Johnson EP, Bushman FD. HIV cDNA metabolism: notable stability of two-long terminal repeat circles. J Virol 2002, 76:3739-3747.
25. Javan CM, Gooderham NJ, Edwards RJ, Davies DS, Shaunak S. Anti-HIV type 1 activity of sulfated derivatives of dextrin against primary viral isolates of HIV type 1 in lymphocytes and monocyte-derived macrophages. AIDS Res Hum Retroviruses 1997, 13:875-880.
26. Andrade WN, Johnston MG, Hay JB. The relationship of blood lymphocytes to the recirculating lymphocyte pool. Blood 1998, 91:1653-1661.
27. Stekel DJ. The simulation of density-dependent effects in the recirculation of T lymphocytes. Scand J Immunol 1998, 47:426-430.